Herceptin plus tykerb makes breast cancer tumours 'disappear'

Results of a clinical trial of patients with HER2-positive breast cancer were presented at the European Breast Cancer Conference in Amsterdam. Patients treated with a combination of herceptin plus lapatinib showed significantly decreased tumour mass. The Independent
Source: Society for Endocrinology - Category: Endocrinology Source Type: news